AHR-10282,
bromfenac,
bromfenac sodium,
Duract,
ISV-303,
sodium bromfenac,
Xibrom,
Bromfenac,
91714-94-2,
2-(2-Amino-3-(4-bromobenzoyl)phenyl)acetic acid,
Xibrom,
Duract,
Bromfenaco,
Bromfenacum,
Bromfenac [INN],
Prolensa,
Bromfenacum [Latin],
Bromfenaco [Spanish],
Bromday,
AHR-10282,
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid,
[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,
2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid,
Bromfenac (INN),
UNII-864P0921DW,
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-,
C15H12BrNO3,
ISV-303,
CHEBI:240107,
BromSite,
864P0921DW,
AK-85648,
120638-55-3,
AHR-10282B,
4mjq,
AHR 10282,
AC1L1TSW,
AC1Q5DQ7,
CHEMBL1077,
SCHEMBL34411,
MLS004774052,
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid,
GTPL7131,
{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid,
DTXSID7040655,
CTK8B5019,
KS-00000FTU,
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N,
EBD87057,
ZINC2570817,
ANW-47053,
EBD898487,
MFCD00864341,
AKOS015998697,
AN-5545,
API0009095,
DB00963,
GS-3830,
MP-1093,
SB17362,
AJ-41875,
CC-25212,
DA-01153,
SMR003500721,
AB0027651,
AX8118731,
LS-178156,
TC-135798,
4CH-007116,
FT-0710423,
ST24027466,
W9506,
D07541,
Benzeneacetic acid,2-amino-3-(4-bromobenzoyl)-,
638B553,
A844048,
C-23660,
SR-01000941476,
J-519935,
SR-01000941476-2,
BRD-K47679368-323-01-3,
2-[2-azanyl-3-(4-bromophenyl)carbonyl-phenyl]ethanoic acid,
2-{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid,
2-[2-amino-3-[(4-bromophenyl)-oxomethyl]phenyl]acetic acid,
27R,
BROMFENAC SODIUM,
Yellox,
sodium bromfenac,
Bromfenac ophthalmic,
Duract (TN),
Xibrom (TN),
BROMFENAC ACID,
Bromfenac Sodium Sesquihydrate,
Bromfenac sodium [USAN],
D0U1OM,
Bromfenac ophthalmic solution,
UNII-8ECV571Y37,
C15-H12-Br-N-O3,
AHR 10282B,
CID60726,
C15H12BrNO3.3/2H2O.Na,
C15-H12-Br-N-O3.3/2H2-O.Na,
2601A,
C053083,
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate,
Sodium (2-amino-3-(p-bromobenzoyl)phenyl)acetate sesquihydrate,